BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2013
View Archived Issues
Receptos licenses RPC-4046 from AbbVie
Read More
NAT2 study finds prevention of exudative age-related macular degeneration with DHA/EPA
Read More
Modified western blot assay detects Plasmodium circumsporozoite protein
Read More
Personal Genome Diagnostics licenses rights to genome mapping technology
Read More
ANAVEX 2-73 protects against Abeta25-35 toxicity in Alzheimer's disease mouse models
Read More
Biomaterial for prevention of heart failure found safe, effective in preclinical studies
Read More
OG-L002 helps demonstrate role of LSD1 in regulation of HSV infection
Read More
Improved tolerability of tolterodine/pilocarpine fixed-dose combination without loss of efficacy
Read More
Japanese scientists divulge novel PDE10A inhibitors
Read More
Hyperuricemia therapy patented by Kissei Pharmaceutical
Read More
Novel antipsychotic drugs reported by Merck & Co.
Read More
Trimel reports pivotal phase III data for CompleoTRT
Read More
Novel O-GlcNAcase inhibitors disclosed in Germany
Read More
Novo Nordisk reports data from phase IIIa liraglutide study
Read More
Long-term fingolimod treatment of relapsing-remitting MS proven safe in FREEDOMS II extension study
Read More
MethylGene reports data from phase II MGCD-290 trial
Read More
PI3K inhibitors disclosed by GlaxoSmithKline
Read More
FDA grants orphan drug status to a recombinant fusion protein and an AAV-G6Pase vector
Read More
Alnylam begins phase I ALN-TTRsc trial in TTR-mediated amyloidosis
Read More
Virobay and LEO Pharma begin phase I trial of VBY-891
Read More
Supplemental BLA submitted to expand Adcetris use in U.S.
Read More
Pegasys receives E.U. approval for HCV in children 5 years of age and older
Read More
Regen BioPharma receives FDA IND number for HemaXellerate
Read More
Bioradar targets Replikin increase in antibiotic-resistant bacterial strains, in vaccine strategy
Read More
FDA clears Quidel and Life Technologies products
Read More